In this week’s issue:
· The Research section within the Faculty of Medicine website has been updated to be a source of information for the general public, including stories about our research excellence, research priorities, and research structure. Information targeted to FoM researchers, such as grant application procedures, deadlines, and grant support, has been moved to MedNet.
· Canadian Student Health Research Forum – Travel Award
· UBC – 2014 Diane Minshall Memorial Award
· Autism Speaks – Requests for Applications
· W. Garfield Weston Foundation – 2014 Transformational Research
· The Vancouver Institute – Craig Laronge University of Wisconsin Lecture, by Professor Molly Carnes, M.D.
· Centre for Blood Research – Seminar Series: Hemostasis, Thrombosis and Immunity
Internal deadline: March 24, 2014
The aim of the Canadian Student Health Research Forum (CSHRF) is to provide a venue for the networking, research exposure and recognition of Canada’s most promising research trainees in the health sciences. Universities have been invited on nominate their top PhD students in health sciences for participation in the forum. A limited number of invited participants will also receive travel award funding from CIHR.
The Faculty of Graduate and Postdoctoral Studies (G+PS) will collect nominations on behalf of UBC, to forward to the CSHRF Coordinator. Graduate programs are invited to nominate their top PhD students in health sciences to the Faculty of Graduate Studies. Graduate programs may submit up to 5% of their PhD students in health sciences (for instance, if a program has 40 PhD students in health sciences, it could submit up to 2 nominees). Appropriate selection criteria are to be determined by the graduate programs. Please note that the symposium theme rotates from year to year and should not bias student selection.
Please see the G+PS website for further details.
Deadline: March 31, 2014
The annual award, in honour of the late Diane Minshall, is once again being offered to a UBC student, graduate student, post-doctoral fellow, staff, researcher or technician involved in the study and care of animals used in research. These funds are to be used for the support of travel/attendance at a meeting, conference, workshop or training opportunity.
Applications must be submitted to the Animal Care Committee, by March 31st, 2014.
Further information and the application form is available at http://www.ors.ubc.ca/contents/animal-care.
LOI Deadline: April 16, 2014
Autism Speaks is pleased to announce the opening of this new RFA for Clinical Research on GI and Neurobehavioral Processes.
This RFA seeks proposals for clinical research that will elucidate the relationship of gut-based processes to the neurobehavioral manifestations of ASD, the potential for treatments directed at GI pathology to affect neurobehavior positively, and best clinical approaches to the evaluation of gut and other medical co-morbidity in patients presenting with new neurobehavioral concerns. Proposals should advance the clinical management of GI and associated neurobehavioral problems in ASD, either by performing clinical assessment research, clinical intervention research, or by studying pathophysiologic mechanisms that are amenable to clinical translation in the very near term. Applications may include proposals to perform pilot studies on the safety and efficacy of therapeutic interventions, or larger-scale confirmatory trials if sufficient scientific justification for such trials already exists
Please see website for details
Deadline: May 2, 2014, 2pm EDT
The W. Garfield Weston Foundation is pleased to announce the launch of the 2014 Transformational Research program in neurodegenerative diseases of aging this March.
· Goal: to provide funding to high potential, translational research that will have transformational impact in neurodegenerative diseases of aging.
· Funding: up to $1,500,000 per project over 3 years, up to a maximum of $3.5 million in total for all projects.
· Eligibility: preclinical development of a therapeutic or development of tools that help accelerate development of therapeutics. Researchers must be at or above the level of Assistant Professor or equivalent (as the Principal Applicant). Collaborators must be at the post-doctoral level or above.
The application requires a Letter of Intent due by Friday, May 2nd 2014, 2 p.m. EDT through the Foundation’s online grant management system at https://weston.smartsimple.ca/welcome/neuroscience. Applicants with high potential projects will be invited to submit a proposal in June. Further details on this program are attached and can be found at http://www.westonfoundation.org/Pages/neurotransform2014.aspx.
Date & Time: March 15, 2014, 8:15pm
Location: Lecture hall 2, Woodward IRC Building, 2194 Health Sciences Mall, Vancouver
The Vancouver Institute presents:
“Why are John and David more likely to become Department Chair than Joan or Jamal?”
Professor Molly Carnes, M.D.
Department of Medicine
University of Wisconsin
Centre for Blood Research – Seminar Series: Hemostasis, Thrombosis and Immunity
Date & Time: March 19, 2014, 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Nigel Mackman
Senior Scientist and Clinical Professor
UNC McAllister Heart Institute
Tissue factor (TF) is the primary activator the coagulation cascade. We have studied the regulation of TF gene expression and generated different transgenic mouse lines to study its roles in hemostasis and thrombosis. Our studies suggest that induction of TF expression in monocytes contributes to arterial thrombosis in hyperlipidemia, and tumor-derived TF-positive microparticles may trigger venous thrombosis in cancer patients. Coagulation proteases also activate a variety of cells by cleavage of protease-activated receptors (PARs). We found that mice lacking PAR-1 have increased cardiac injury in a coxsackievirus-induced myocarditis model. Further studies suggested that PAR-1 contributes to the innate immune response to coxsackievirus by enhancing IFN-beta expression. This study indicates that that is crosstalk between the clotting cascade and other processes, such as the inflammation and the innate immune response to viral infection.